Given the central role of IL-6 in the inflammatory pathology of COVID-19 and the consistent association between elevated IL-6 levels and severe disease outcomes observed early in the pandemic, we aim to analyse IL-6 and its soluble receptor complex behaviour across different waves of the COVID-19 pandemic. The gene discussed is IL6; the disease is COVID-19.